Skip to main content
Article thumbnail
Location of Repository

A 26-week randomized parallel treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naïve people with type 2 diabetes.

By K. Hermansen, Melanie J. Davies, T. Derezinski, G. Martines Ravn, P. Clauson, P. Home and Levemir Treat-to-Target Study Group
Year: 2006
DOI identifier: 10.2337/dc05-1365
OAI identifier:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.